• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    HealthEquity Delivers Record Q4 and Standout Fiscal 2026 Sales Metrics

    2/17/26 4:00:00 PM ET
    $HQY
    Real Estate
    Real Estate
    Get the next $HQY alert in real time by email

    DRAPER, Utah, Feb. 17, 2026 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (NASDAQ:HQY) ("HealthEquity" or the "Company"), the nation's largest health savings account ("HSA") custodian by number of accounts and leading provider of complementary consumer-directed benefits ("CDBs"), today announced its HSAs, HSA Assets, and Total Accounts as of its fiscal year ended January 31, 2026. The Company also reaffirmed its guidance for fiscal 2026 and 2027, provided an updated HSA cash repricing schedule, and announced upcoming events and presentations.

    The total number of HSAs as of January 31, 2026 was 10.6 million, an increase of 7% from 9.9 million as of January 31, 2025. The Company closed fiscal year 2026 with 17.8 million Total Accounts, an increase of 4% from 17.0 million as of January 31, 2025. HSA Assets grew to $36.5 billion as of January 31, 2026, an increase of 14% from $32.1 billion a year earlier. Fourth-quarter new HSAs from sales rose 17% year over year. HSA investments increased 26% year over year to $18.5 billion.

    "HealthEquity delivered a standout fiscal 2026 sales year, driven by a record fourth quarter and our strongest year yet for HSA additions—adding more than one million new HSA accounts from sales," said Scott Cutler, President and CEO of HealthEquity.

    "Against softer U.S. job growth, we generated record new HSA sales as employers turned to HSAs to address rising healthcare costs. Open-enrollment execution drove increased utilization of HSA-eligible plans with enterprise clients, higher retail enrollment supported by product enhancements, and early momentum among newly eligible American families."

    "We maintained high client retention and are entering the new fiscal year with a growing enterprise pipeline. As healthcare affordability pressures persist nationally, we are advocating for regulatory changes so more Americans can take greater control over how they pay for healthcare."

    Dr. Steve Neeleman, Founder and Vice Chair, added, "We're encouraged by bipartisan efforts to broaden access to HSAs and expand categories of HSA-eligible expenses. HSAs put families in control of their healthcare dollars and help Americans make more informed healthcare decisions."

    Total Accounts (unaudited)

    (in thousands, except percentages)January 31, 2026 January 31, 2025 % Change
    HSAs10,570 9,889 7%
    New HSAs from sales - Quarter-to-date553 471 17%
    New HSAs from sales - Year-to-date1,040 1,040 0%
    New HSAs from acquisitions - Year-to-date— 616 *
    HSAs with investments832 753 10%
    CDBs7,221 7,144 1%
    Total Accounts17,791 17,033 4%
    Average Total Accounts - Quarter-to-date17,462 16,677 5%
    Average Total Accounts - Year-to-date17,220 16,302 6%

    * Not meaningful



    HSA Assets (unaudited)

    (in millions, except percentages)January 31, 2026 January 31, 2025 % Change
    HSA cash$17,982 $17,435 3%
    HSA investments 18,482  14,676 26%
    Total HSA Assets 36,464  32,111 14%
    Average daily HSA cash - Quarter-to-date 17,090  16,634 3%
    Average daily HSA cash - Year-to-date 17,082  16,206 5%



    HSA cash maturity schedule (unaudited)

    The following table summarizes the amount of HSA cash expected to reprice by fiscal year and the respective average annualized yield as of January 31, 2026:

    Year ending January 31, (in billions, except percentages)HSA cash expected to reprice Average annualized

    yield
    2027$4.5 1.9%
    2028 2.3 4.0%
    2029 1.7 3.6%
    2030 2.4 4.4%
    Thereafter 6.4 4.2%
    Total (1)$17.3 3.6%

    (1)  Excludes $0.7 billion of HSA cash held in floating-rate contracts as of January 31, 2026.

    Business outlook

    HealthEquity reaffirmed its previously provided outlook for the fiscal year that ended January 31, 2026, and the fiscal year ending January 31, 2027.

    The Company expects fiscal 2026 results to be near the top end of previously provided ranges. Based on the strong sales results reported today, the Company intends to provide updated full guidance for fiscal 2027 when it reports fiscal 2026 year-end results in March.

    Please see the Company's press releases dated December 3, 2025, and January 12, 2026, for details regarding previously issued outlooks.

    Upcoming events and presentations

    The Company set the date for reporting its fourth quarter and fiscal year 2026 results.

    HealthEquity Fourth Quarter and Fiscal Year End 2026 Results Conference Call
    Date:March 17, 2026
    Time:4:30 p.m. Eastern Time / 2:30 p.m. Mountain Time
    Dial-In:1-833-630-1956 (US and Canada) 1-412-317-1837 (International)
    Conference ID:HealthEquity
    Webcast:ir.healthequity.com
      

    The Company also announced that its management team plans to present and meet with investors at the following upcoming conferences:

    Raymond James 47th Annual Institutional Investors Conference
    Location:JW Marriott Orlando Great Lakes
    Date:March 4, 2026
    Time:9:50 a.m. Eastern Time
    Webcast:None
      
    Mizuho Healthcare Technology Conference
    Location:Virtual
    Date:March 5, 2026
    Time:One-on-one meetings only
    Webcast:None
      

    About HealthEquity

    HealthEquity and its subsidiaries provide HSAs and other consumer-directed benefits for more than 17 million accounts in partnership with employers, benefits advisors, and health and retirement plan providers who share our mission to save and improve lives by empowering healthcare consumers. For more information, visit www.healthequity.com.

    Forward-looking statements

    This press release contains "forward-looking statements" within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995, including but not limited to, statements regarding our New HSAs from Sales, HSA Assets, Total Accounts, industry, business strategy, plans, goals and expectations concerning our markets and market position, product expansion, future operations, expenses and other results of operations, revenue, margins, profitability, acquisition synergies, future efficiencies, tax rates, capital expenditures, liquidity and capital resources and other financial and operating information. When used in this discussion, the words "may," "believes," "intends," "seeks," "aims," "anticipates," "plans," "estimates," "expects," "should," "assumes," "continues," "could," "will," "future" and the negative of these or similar terms and phrases are intended to identify forward-looking statements in this press release.

    Forward-looking statements reflect our current expectations regarding future events, results or outcomes. These expectations may or may not be realized. Although we believe the expectations reflected in the forward-looking statements are reasonable, we can give you no assurance these expectations will prove to be correct. Some of these expectations may be based upon assumptions, data or judgments that prove to be incorrect. Actual events, results and outcomes may differ materially from our expectations due to a variety of known and unknown risks, uncertainties and other factors. Although it is not possible to identify all of these risks and factors, they include, among others, risks related to the following:

    • our ability to adequately place and safeguard our custodial assets, or the failure of any of our depository or insurance company partners;
    • our ability to compete effectively in a rapidly evolving healthcare and benefits administration industry;
    • our dependence on the continued availability and benefits of tax-advantaged HSAs and other CDBs;
    • the impact of fraudulent account activity involving our member accounts or our third-party service providers on our reputation and financial results;
    • our ability to successfully identify, acquire and integrate additional portfolio purchases or acquisition targets;
    • the significant competition we face and may face in the future, including from those with greater resources than us;
    • our reliance on the availability and performance of our technology and communications systems;
    • potential future cybersecurity breaches of our technology and communications systems and other data interruptions, including resulting costs and liabilities, reputational damage and loss of business;
    • the current uncertain healthcare environment, including changes in healthcare programs and expenditures and related regulations;
    • our ability to comply with current and future privacy, healthcare, tax, ERISA, investment adviser and other laws applicable to our business;
    • our reliance on partners and third-party vendors for distribution and important services;
    • our ability to develop and implement updated features for our technology platforms and communications systems; and
    • our reliance on our management team and key team members.

    For a detailed discussion of these and other risk factors, please refer to the risks detailed in our filings with the Securities and Exchange Commission, including, without limitation, our Annual Report on Form 10-K for the fiscal year ended January 31, 2025, and subsequent periodic and current reports. Past performance is not necessarily indicative of future results. We undertake no intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. Forward-looking statements should not be relied upon as representing our views as of any date subsequent to the date of this press release.

    Investor Relations Contact

    Richard Putnam

    801-727-1000

    rputnam@healthequity.com

    Certain terms

    TermDefinition
    HSAA financial account through which consumers spend and save long-term for healthcare on a tax-advantaged basis.
    CDBConsumer-directed benefits offered by employers, including flexible spending and health reimbursement arrangements ("FSAs" and "HRAs"), Consolidated Omnibus Budget Reconciliation Act ("COBRA") administration, commuter and other benefits.
    HSA memberConsumers with HSAs that we serve.
    Total HSA AssetsHSA members' custodial cash assets held by our federally insured depository partners and our insurance company partners. Total HSA Assets also includes HSA members' investments in mutual funds through our custodial investment fund partner.
    Total AccountsThe sum of HSAs and CDBs on our platforms.


    Primary Logo

    Get the next $HQY alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $HQY

    DatePrice TargetRatingAnalyst
    1/9/2026$89.00Neutral → Sell
    Goldman
    12/9/2025$118.00Overweight
    Barclays
    11/13/2025$100.00Market Perform
    BMO Capital Markets
    5/22/2025$105.00 → $112.00Outperform
    RBC Capital Mkts
    3/25/2025$120.00 → $115.00Outperform → Strong Buy
    Raymond James
    12/4/2024$126.00Outperform
    Mizuho
    11/15/2024$108.00Neutral
    Goldman
    4/4/2024$101.00Mkt Outperform
    JMP Securities
    More analyst ratings

    $HQY
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Parker Stuart B. was granted 1,263 shares, increasing direct ownership by 6% to 23,098 units (SEC Form 4)

    4 - HEALTHEQUITY, INC. (0001428336) (Issuer)

    2/4/26 1:06:09 PM ET
    $HQY
    Real Estate

    Director Natarajan Rajesh was granted 976 shares, increasing direct ownership by 7% to 15,253 units (SEC Form 4)

    4 - HEALTHEQUITY, INC. (0001428336) (Issuer)

    2/4/26 1:01:53 PM ET
    $HQY
    Real Estate

    President and CEO Cutler Scott covered exercise/tax liability with 12,496 shares, decreasing direct ownership by 10% to 109,820 units (SEC Form 4)

    4 - HEALTHEQUITY, INC. (0001428336) (Issuer)

    1/14/26 4:18:23 PM ET
    $HQY
    Real Estate

    $HQY
    SEC Filings

    View All

    HealthEquity Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - HEALTHEQUITY, INC. (0001428336) (Filer)

    2/17/26 4:06:18 PM ET
    $HQY
    Real Estate

    HealthEquity Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - HEALTHEQUITY, INC. (0001428336) (Filer)

    1/12/26 9:01:35 AM ET
    $HQY
    Real Estate

    SEC Form 10-Q filed by HealthEquity Inc.

    10-Q - HEALTHEQUITY, INC. (0001428336) (Filer)

    12/3/25 4:04:09 PM ET
    $HQY
    Real Estate

    $HQY
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    HealthEquity downgraded by Goldman with a new price target

    Goldman downgraded HealthEquity from Neutral to Sell and set a new price target of $89.00

    1/9/26 8:49:40 AM ET
    $HQY
    Real Estate

    Barclays initiated coverage on HealthEquity with a new price target

    Barclays initiated coverage of HealthEquity with a rating of Overweight and set a new price target of $118.00

    12/9/25 8:49:54 AM ET
    $HQY
    Real Estate

    BMO Capital Markets initiated coverage on HealthEquity with a new price target

    BMO Capital Markets initiated coverage of HealthEquity with a rating of Market Perform and set a new price target of $100.00

    11/13/25 9:13:59 AM ET
    $HQY
    Real Estate

    $HQY
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Phreesia Appoints Jon Kessler to Board of Directors

    Industry Veteran Brings Track Record of Technology-Driven Growth and Value Creation Edward L. Cahill and Michael Weintraub to Retire at 2026 Annual Meeting of Stockholders Phreesia, Inc. (NYSE:PHR) ("Phreesia" or the "Company") today announced that it has appointed Jon Kessler to its Board, effective April 6, 2026. In addition, Edward L. Cahill and Michael Weintraub have informed the Board that they will retire from the Board, effective at the 2026 Annual Meeting. Mr. Kessler is an experienced public company CEO and director who will bring valuable expertise to the Phreesia Board. As founder, Chairman and CEO of WageWorks and most recently President and CEO of HealthEquity (NASDAQ:HQY

    2/23/26 4:03:00 PM ET
    $HQY
    $PHR
    Real Estate

    HealthEquity Delivers Record Q4 and Standout Fiscal 2026 Sales Metrics

    DRAPER, Utah, Feb. 17, 2026 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (NASDAQ:HQY) ("HealthEquity" or the "Company"), the nation's largest health savings account ("HSA") custodian by number of accounts and leading provider of complementary consumer-directed benefits ("CDBs"), today announced its HSAs, HSA Assets, and Total Accounts as of its fiscal year ended January 31, 2026. The Company also reaffirmed its guidance for fiscal 2026 and 2027, provided an updated HSA cash repricing schedule, and announced upcoming events and presentations. The total number of HSAs as of January 31, 2026 was 10.6 million, an increase of 7% from 9.9 million as of January 31, 2025. The Company closed fiscal year

    2/17/26 4:00:00 PM ET
    $HQY
    Real Estate

    HealthEquity Announces Fiscal Year 2027 Outlook Presentation at J.P. Morgan Healthcare Conference

    DRAPER, Utah, Jan. 12, 2026 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (NASDAQ:HQY) ("HealthEquity" or the "Company"), the nation's largest health savings account ("HSA") custodian by number of accounts and leading provider of complimentary consumer-directed benefits ("CDBs"), today announced its initial outlook for its fiscal year ending January 31, 2027 and reaffirmed previously provided guidance for its fiscal year ending January 31, 2026. For the fiscal year ending January 31, 2027, management expects revenues in the range of $1.38 billion to $1.41 billion with Adjusted EBITDA margin of 43.8% to 44.3% and a yield on HSA Cash of approximately 3.75%. "Today, we issued our initial fiscal 20

    1/12/26 8:50:00 AM ET
    $HQY
    Real Estate

    $HQY
    Leadership Updates

    Live Leadership Updates

    View All

    HealthEquity Strengthens Executive Leadership Team with Strategic Appointments to Drive Growth and Innovation

    DRAPER, Utah, Sept. 25, 2025 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (NASDAQ: HQY), the nation's largest Health Savings Accounts (HSAs) and consumer-directed benefits administrator, today announced the appointment of new senior executives to accelerate the company's strategic vision and capitalize on expanding market opportunities. Mukund Ramachandran joins as Chief Marketing Officer and Garett Kitch as Senior Vice President of Client Sales & Relationship Management, effective September 29, 2025. The appointments come as HealthEquity continues to execute against record financial performance, alongside the largest HSA eligibility expansion in 20 years following recent federal legislation.

    9/25/25 9:00:00 AM ET
    $HQY
    Real Estate

    HealthEquity Reports Year-End Sales Metrics

    DRAPER, Utah, Feb. 18, 2025 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (NASDAQ:HQY) ("HealthEquity" or the "Company"), the nation's largest health savings account ("HSA") custodian, today announced its HSAs, HSA Assets and Total Accounts as of its fiscal year ended January 31, 2025. The Company also affirmed its guidance for fiscal 2025 and 2026, provided an updated HSA cash repricing schedule, and announced upcoming events and presentations. The total number of HSAs as of January 31, 2025 was 9.9 million, an increase of 14%, from 8.7 million as of January 31, 2024. The Company closed its fiscal year 2025 with 17.0 million Total Accounts, an increase of 9%, from 15.7 million as of January 31,

    2/18/25 4:01:00 PM ET
    $HQY
    Real Estate

    HealthEquity Announces Record Year-End HSA Sales Outlook, Presentation at J.P. Morgan Healthcare Conference

    DRAPER, Utah, Jan. 13, 2025 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (NASDAQ:HQY) ("HealthEquity" or the "Company"), the nation's largest health savings account ("HSA") custodian, today announced estimates of HSAs, HSA Assets and Total Accounts for its fiscal year ending January 31, 2025, reflecting a strong sales year with record New HSAs from Sales and strong custodial HSA Asset growth. Estimated HSAs to be approximately 9.8 million by January 31, 2025, up from 8.7 million a year earlier.Estimated HSA Assets to be approximately $31 billion, up from $25.2 billion at the end of fiscal year 2024, with approximately $17 billion of HSA Cash. Invested balances included in the estimated assets a

    1/13/25 9:01:00 AM ET
    $HQY
    Real Estate

    $HQY
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by HealthEquity Inc. (Amendment)

    SC 13G/A - HEALTHEQUITY, INC. (0001428336) (Subject)

    2/13/24 5:06:19 PM ET
    $HQY
    Real Estate

    SEC Form SC 13G/A filed by HealthEquity Inc. (Amendment)

    SC 13G/A - HEALTHEQUITY, INC. (0001428336) (Subject)

    2/9/24 4:15:05 PM ET
    $HQY
    Real Estate

    SEC Form SC 13G/A filed by HealthEquity Inc. (Amendment)

    SC 13G/A - HEALTHEQUITY, INC. (0001428336) (Subject)

    2/9/24 9:16:06 AM ET
    $HQY
    Real Estate

    $HQY
    Financials

    Live finance-specific insights

    View All

    HealthEquity Reports Third Quarter Ended October 31, 2025 Financial Results

    Highlights of the third quarter include: Revenue increased 7% to $322.2 million.Net income per diluted share rose to $0.59 from $0.06 one year ago, and non-GAAP net income per diluted share increased 29% to $1.01.Total HSA Assets grew 15% to $34.4 billion.Returned $93.7 million to shareholders through stock repurchases.Further reduced HSA cash repricing risk with a cumulative $2.25 billion 5-year Treasury bond hedge at 3.94%. DRAPER, Utah, Dec. 03, 2025 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (NASDAQ:HQY) ("HealthEquity" or the "Company"), a leader in administering health savings accounts ("HSAs") and complementary consumer-directed benefits ("CDBs"), today announced financial results for

    12/3/25 4:01:00 PM ET
    $HQY
    Real Estate

    HealthEquity Announces Third Quarter Earnings Date

    DRAPER, Utah, Nov. 05, 2025 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (NASDAQ:HQY) ("HealthEquity" or the "Company"), the nation's largest Health Savings Accounts ("HSA") and consumer-directed benefits administrator, today announced plans to release financial results of its third quarter of fiscal 2026 following the close of regular stock market trading hours on Wednesday, December 3, 2025. Following the news release, HealthEquity management plans to host a conference call for investors on Wednesday, December 3, 2025, at 4:30 p.m. Eastern Time during which management will review the Company's financial results. HealthEquity Third Quarter Fiscal Year 2026 Results Conference CallDate: December

    11/5/25 4:01:00 PM ET
    $HQY
    Real Estate

    HealthEquity Reports Second Quarter Ended July 31, 2025 Financial Results

    Highlights of the second quarter include: Revenue of $325.8 million, an increase of 9% compared to $299.9 million in Q2 FY25.Net income of $59.9 million, an increase of 67% compared to $35.8 million in Q2 FY25, with non-GAAP net income of $94.6 million, an increase of 24% compared to $76.3 million in Q2 FY25.Net income per diluted share of $0.68, an increase of 70% compared to $0.40 in Q2 FY25, with non-GAAP net income per diluted share of $1.08, an increase of 26% compared to $0.86 in Q2 FY25.Adjusted EBITDA of $151.1 million, an increase of 18% compared to $128.3 million in Q2 FY25.10.0 million HSAs, an increase of 6% compared to Q2 FY25.Total HSA Assets of $33.1 billion, an increase of

    9/2/25 4:01:00 PM ET
    $HQY
    Real Estate